October 5, 2013

Conference Scene: Novelties in immunotherapy

Full Text
October 2013, Vol. 5, No. 10, Pages 1033-1037 , DOI 10.2217/imt.13.109
(doi:10.2217/imt.13.109)

Dimitris I Mitsias1Lampros A Kalogiros1 & Nikolaos G Papadopoulos*1
* Author for correspondence
Sections: 



ABSTRACT
Next section
European Academy of Allergology and Clinical Immunology – World Allergy Organization World Allergy and Asthma Congress, Milan, Italy, 22–26 June 2013
The only method aiming to permanently cure allergic disorders is allergen immunotherapy. Over the last 20 years there has been great progress in understanding the mechanisms that govern allergen immunotherapy in order to meet three basic prerequisites: safety, effectiveness and compliance. In the present summary report from the European Academy of Allergology and Clinical Immunology–World Allergy Organization Congress held last June in Milan, we review key points concerning the main axes as diagnosis, novel modalities, routes and protocols, as well as two important immunotherapy fields: food and insect venom allergy.

No comments:

Post a Comment